Theseus Pharmaceuticals Stock Price

-0.12 (-2.26%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 149,784
Bid Price 4.75
Ask Price 17.00
News -
Day High 5.86


52 Week Range


Day Low 4.945
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Theseus Pharmaceuticals Inc THRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.12 -2.26% 5.20 17:30:01
Open Price Low Price High Price Close Price Prev Close
5.43 4.945 5.86 5.20 5.32
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,076 149,784 $ 5.16 $ 772,759 - 4.857 - 24.54
Last Trade Time Type Quantity Stock Price Currency
16:08:07 formt 1,594 $ 5.20 USD


Draw Mode:

Theseus Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 201.25M 38.70M 15.59M $ - $ - -2.97 -1.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 60.00k 4.90%

more financials information »

Theseus Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical THRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.986.564.9455.99215,867-0.78-13.04%
1 Month6.856.9354.8575.88175,175-1.65-24.09%
3 Months14.0714.604.8577.0697,578-8.87-63.04%
6 Months10.7115.214.8578.8387,089-5.51-51.45%
1 Year20.8024.544.85712.78164,229-15.60-75.0%
3 Years20.8024.544.85712.78164,229-15.60-75.0%
5 Years20.8024.544.85712.78164,229-15.60-75.0%

Theseus Pharmaceuticals Description

Theseus Pharmaceuticals Inc is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. The company's development programs are designed to address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer.
Your Recent History
Theseus Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220630 01:01:41